methamphetamine has been researched along with 3,4-dihydroxyphenylacetic acid in 181 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (11.05) | 18.7374 |
1990's | 69 (38.12) | 18.2507 |
2000's | 65 (35.91) | 29.6817 |
2010's | 23 (12.71) | 24.3611 |
2020's | 4 (2.21) | 2.80 |
Authors | Studies |
---|---|
Dall'Olio, R; Gandolfi, O; Rimondini, R | 1 |
Nash, JF; Yamamoto, BK | 1 |
Akiyama, K; Kanzaki, A; Otsuki, S | 1 |
Marshall, JF; O'Dell, SJ; Weihmuller, FB | 3 |
Akimoto, K; Akiyama, K; Hamamura, T; Kashihara, K; Okumura, K; Otsuki, S; Ujike, H | 1 |
Camp, DM; Paulson, PE; Robinson, TE; Yew, J | 1 |
Kleven, MS; Seiden, LS | 1 |
Hamamura, T; Kashihara, K; Okumura, K; Otsuki, S | 1 |
Cole, BN; Marshall, JF; O'Dell, SJ; Weihmuller, FB | 1 |
Hashiguchi, H; Hashitani, T; Ikeda, T; Ishida, Y; Nishino, H; Yamamoto, R | 1 |
Kashihara, K; Okumura, K; Onishi, M; Otsuki, S | 1 |
Hashitani, T; Ikeda, T; Ishida, Y; Kumazaki, M; Nishino, H | 1 |
Matsunaga, T; Morita, M; Takeda, N; Wada, H; Yamatodani, A | 1 |
Gibb, J; Hanson, G; Matsuda, L | 1 |
Kleven, MS; Seiden, LS; Woolverton, WL | 1 |
Fujiwara, M; Kataoka, Y; Mine, K; Sakurai-Yamashita, Y; Ueki, S | 1 |
Gibb, JW; Hanson, GR; Peat, MA; Schmidt, CJ; Sonsalla, PK | 1 |
Gibb, JW; Schmidt, CJ | 2 |
Nomura, Y; Sekihara, S; Watanabe, H | 1 |
Seiden, LS | 1 |
Kaneno, S; Takahashi, R; Watanabe, A | 1 |
Hamamura, T; Kazahaya, Y; Otsuki, S | 1 |
Fukuda, K; Kashihara, K; Otsuki, S; Sato, M | 1 |
Aihara, H; Hashimoto, S; Kamata, K; Kasuya, Y; Kumura, MA; Okuyama, S | 1 |
Fujiwara, Y; Fukuda, K; Kashihara, K; Otsuki, S; Sato, M | 1 |
Watanabe, H | 1 |
Mataga, N; Nishikawa, T; Takashima, M; Toru, M | 2 |
Guillery, RW; Moore, RY; Ricaurte, GA; Schuster, CR; Seiden, LS | 1 |
Seiden, LS; Vosmer, G | 1 |
Ricaurte, GA; Schuster, CR; Seiden, LS | 1 |
Calne, DB; Chuang, LW; Eisler, T; Karoum, F; Klein, DF; Liebowitz, MR; Quitkin, FM; Wyatt, RJ | 1 |
Boireau, A; Bordier, F; Doble, A; Dubédat, P | 1 |
Ali, SF | 1 |
Ali, SF; Bowyer, JF; Holson, W; Newport, RR; Slikker, W | 1 |
Ali, S; Cadet, JL; Carlson, E; Epstein, C; Rothman, R; Sheng, P | 1 |
Abekawa, T; Koyama, T; Ohmori, T | 3 |
Ali, S; Cadet, JL; Epstein, C | 1 |
Ali, SF; Bowyer, JF; Holson, RR; Newport, GD; Slikker, W | 2 |
Wagner, GC; Yu, YL | 1 |
King, LA; Kita, T; Lowndes, HE; Philbert, MA; Wagner, GC | 1 |
Cappon, GD; Fisher, JE; Pu, C; Vorhees, CV | 1 |
Hashiguti, H; Maruyama, W; Nakahara, D; Naoi, M | 1 |
Bowyer, JF; Gough, B; Holson, RR; Lipe, GW; Newport, GD; Slikker, W | 1 |
Akiyama, K; Fujiwara, Y; Kanzaki, A; Tsuchida, K; Ujike, H | 1 |
Ikawa, K; Kaneno, S; Motohashi, N; Watanabe, A | 1 |
Bland, LR; Layer, RT; Skolnick, P | 1 |
Shibuya, H; Toru, M; Watanabe, A; Yoshikawa, T | 1 |
Bowyer, JF; Broening, HW; Gough, B; Newport, GD; Schmued, L | 1 |
Hirobe, M; Nagao, T; Ohta, S; Ono, H; Tateyama, M | 1 |
Baldwin, HA; Colado, MI; De Souza, RJ; Green, AR; Murray, TK | 1 |
Adams, FS; Edwards-Prasad, J; Freed, CR; Kentroti, S; Kumar, S; La Rosa, FG; Prasad, KN; Vernadakis, A | 1 |
Ali, SF; Itzhak, Y | 2 |
Akiyama, K; Kuroda, S; Li, X; Sakai, K; Tsuchida, K; Ujike, H | 1 |
Hashimoto, A; Iwama, H; Kashiwa, A; Nishijima, K; Nishikawa, T; Umino, A | 1 |
Delle Donne, KT; Sonsalla, PK | 1 |
Cadet, JL; Ladenheim, B; Moran, TH; Sheng, P; Wang, XB | 1 |
Di Monte, DA; Jakowec, MW; Langston, JW; Royland, JE | 1 |
Bowyer, JF; Clausing, P; Gough, B; Holson, RR | 1 |
Ali, SF; Newport, GD; Slikker, W | 1 |
Shimada, A; Yamaguchi, K; Yanagita, T | 1 |
Ali, SF; Binienda, Z; Sandberg, JA; Slikker, W | 1 |
Hashitani, T; Hattori, S; Matsui, N; Nishino, H | 1 |
Finnegan, KT; Taraska, T | 1 |
Kim, HS; Oh, KW; Wagner, GC | 1 |
Abekawa, T | 1 |
Bunzow, JR; Chester, JA; Dziewczapolski, G; Falzone, TL; Fang, Y; Gershanik, O; Grandy, DK; Larson, JL; Low, MJ; McDougall, JA; Phillips, TJ; Pugsley, TA; Rubinstein, M; Saez, C; Zhang, G | 1 |
Fasciano, J; Hatzidimitriou, G; Katz, JL; Ricaurte, GA; Yuan, J | 1 |
Ali, SF; Freyaldenhoven, TE; Kuperman, DI; Schmued, LC | 1 |
Andersen, JK; Jurma, OP; Wei, Q | 1 |
Hashitani, T; Kumazaki, M; Mizukawa, K; Nishino, H | 1 |
Golembiowska, K; Zylewska, A | 1 |
Callahan, BT; Ricaurte, GA | 1 |
Huang, J; Kita, T; Lowndes, HE; Philbert, MA; Wagner, GC | 1 |
Kita, T; Kubo, K; Nakashima, T; Takahashi, M; Wagner, GC | 1 |
Alessandrì, MG; Corsini, GU; Fornai, F; Giorgi, FS; Giusiani, M | 1 |
Hastings, TG; LaVoie, MJ | 1 |
Ali, SF; Imam, SZ; Islam, F; Newport, GD; Slikker, W | 1 |
Burrows, KB; Meshul, CK | 1 |
Cass, WA; Manning, MW; Walker, DJ | 1 |
Ali, SF; Crow, JP; Imam, SZ; Islam, F; Newport, GD; Slikker, W | 1 |
Cass, WA; Manning, MW | 1 |
Ali, SF; Itzhak, Y; Martin, JL | 1 |
Ali, SF; Imam, SZ | 2 |
Kurachi, M; Sumiyoshi, T; Tanii, Y; Uehara, T | 1 |
Bing, G; Jhoo, W; Kim, H; Shin, E | 1 |
Kita, T; Kubo, K; Matsunari, Y; Nakashima, T; O'Hara, K; Saraya, T; Shimada, K; Wagner, GC | 1 |
Kim, S; McCann, UD; Ricaurte, GA; Xie, T; Yuan, J | 1 |
Bailey, SL; Cass, WA; Manning, MW | 1 |
Ali, SF; Imam, SZ; Islam, F; Itzhak, Y; Slikker, W | 1 |
Ali, SF; Miller, DB; O'Callaghan, JP | 1 |
Ali, SF; Bondy, SC; Kleinman, MT | 1 |
Acri, JB; Crooks, PA; Dwoskin, LP; Goldberg, SR; Miller, DK; Munzar, P; Teng, L; Witkin, JM | 1 |
Douchi, T; Nomoto, M; Ohtani, H | 1 |
Callahan, BT; McCann, UD; Ricaurte, GA; Yuan, J | 1 |
Goto, K; Ikemoto, S; Ishiguro, T; Nishijima, K; Yoshino, T; Yui, K | 1 |
Barrett, T; Becker, KG; Cheadle, C; Chrest, FJ; Dillon-Carter, O; Donovan, DM; Freed, WJ; Juhaszova, M; Kargul, GJ; Ko, MS; Lim, MK; McCann, UD; Piao, Y; Ricaurte, GA; Rowley, DL; Vawter, MP; Wersto, R; Wood, WH; Xie, T; Zhou, L | 1 |
Gluck, MR; Hogan, KA; Jayatilleke, E; Manzino, L; Moy, LY; Sonsalla, PK | 1 |
Dluzen, DE; Kalinski, MI; Stadulis, R | 1 |
Bubula, N; Heller, A; Won, L | 1 |
Barrett, T; Becker, KG; Donovan, DM; Hatzidimitriou, G; McCann, UD; Ricaurte, GA; Tong, L; Xie, T; Yuan, J | 1 |
Abekawa, T; Honda, M; Ito, K; Koyama, T; Ohmori, T | 1 |
Aloisi, G; Battaglia, G; Busceti, CL; Cerrito, F; De Blasi, A; Fornai, F; Melchiorri, D; Nicoletti, F | 1 |
Bisagno, V; Ferguson, D; Luine, VN | 1 |
Halliwell, B; Jenner, P; Spencer, JP; Whiteman, M | 1 |
Ali, SF; Blough, B; Gough, B; Imam, SZ; Slikker, W | 1 |
Ali, SF; Gough, B; Imam, SZ; Macedo, TR; Newport, GD; Pereira, FC; Ribeiro, CF; Slikker, W | 1 |
Ito, C; Kubota, Y; Ohtsu, H; Sakurai, E; Watanabe, T | 1 |
Cass, WA; Guseva, M; Maragos, WF; Nath, A; Pauly, JR; Turchan, JT; Young, KL | 1 |
Bardo, MT; Dwoskin, LP; Gehrke, BJ; Green, TA; Harrod, SB | 1 |
Glick, SD; Maisonneuve, IM; Shoblock, JR; Sullivan, EB | 1 |
Bardo, MT; Cass, WA; Gehrke, BJ; Harrod, SB | 1 |
Crawford, CA; McDougall, SA; Newman, ER; Vorhees, CV; Williams, MT | 1 |
Alessandrí, MG; Fornai, F; Geppert, M; Jahn, R; Schlüter, OM; Südhof, TC; Takamori, S | 1 |
Cho, AK; Kuczenski, R; Melega, WP; O'Neil, ML; Segal, DS | 2 |
Aoki, K; Kuzumaki, N; Narita, M; Suzuki, T; Takagi, M | 1 |
Battaglia, G; Busceti, CL; De Blasi, A; Fornai, F; Lembo, G; Nicoletti, F | 1 |
Anderson, LI; Dluzen, DE; Gajjar, TM | 1 |
Chen, HH; Cherng, CG; Chuang, KP; Kuo, YM; Shieh, CC; Yu, L | 1 |
Dluzen, DE; Joyce, JN; Kucera, J; Osredkar, T; Renish, L; Walro, JM | 1 |
D'Astous, M; Di Paolo, T; Dluzen, DE; Gajjar, TM | 1 |
Dluzen, DE; Mickley, KR | 1 |
Cherng, CG; Hsu, HC; Kuo, YM; Liao, PC; Yu, L | 1 |
Cass, WA; Maragos, WF; Theodore, S | 1 |
Miller, DB; O'Callaghan, JP; Sriram, K | 1 |
Crutchfield, KC; Dluzen, DE | 1 |
Ali, SF; Borges, F; Lourenço, ES; Macedo, TR; Morgadinho, T; Pereira, FC; Ribeiro, CF | 1 |
Dluzen, DE; Liu, B | 2 |
Cho, AK; Kuczenski, R; Lacan, G; Melega, WP; O'Neil, ML; Segal, DS | 1 |
Chiba, T; Fukuda, T; Hatano, T; Hattori, N; Kai, N; Kakiuchi, T; Kobayashi, K; Mizuno, Y; Nishiyama, S; Sato, S; Tanaka, K; Tsukada, H; Yasoshima, Y | 1 |
Ali, SF; Lourenço, E; Macedo, TR; Milhazes, N; Morgadinho, T; Pereira, FC; Ribeiro, CF | 1 |
Melo, P; Rodrigues, LG; Silva, MC; Tavares, MA | 1 |
Cherng, CG; Kuo, YM; Liao, PC; Lin, YC; Su, SW; Yu, L | 1 |
Chen, Q; Davidson, C; Ellinwood, EH; Lazarus, C; Lee, TH; Xiong, X; Zhang, X | 1 |
Ho, IK; Lan, KC; Lin-Shiau, SY; Liu, SH; Ma, T | 1 |
Li, Y; Qi, J; Song, M; Wang, F; Wu, CF; Yang, JY | 1 |
Dluzen, DE; Ji, J | 1 |
Birdsall, E; Chu, PW; Fleckenstein, AE; Hanson, GR; Metcalf, CS; Riordan, JA; Seferian, KS; Truong, JG | 1 |
Dluzen, DE; McDermott, JL | 1 |
Cadet, JL; Deng, X; Gardner, EL; Kleitz, HK; Ladenheim, B; Li, X; Peng, XQ; Stein, EA; Xi, ZX | 1 |
Ali, S; Duhart, H; Lyn-Cook, BD; Newport, G; Tareke, E | 1 |
Bubenikova-Valesova, V; Hruba, L; Janovsky, M; Kacer, P; Rambousek, L; Schutova, B; Slamberova, R; Syslova, K | 1 |
Kalivas, PW; McGinty, JF; Pacchioni, AM; Rocha, A; Schwendt, M; See, RE | 1 |
Hagiwara, H; Hashimoto, K; Iyo, M | 1 |
Crooks, PA; Deaciuc, G; Dwoskin, LP; Krishnamurthy, S; Nickell, JR; Norrholm, S; Siripurapu, KB; Zheng, G | 1 |
Kitanaka, J; Kitanaka, N; Takemura, M; Watabe, K | 1 |
Darvesh, AS; Dluzen, DE; McDermott, JL | 1 |
Ali, SF; Bondy, SC | 1 |
Bardo, MT; Beckmann, JS; Crooks, PA; Denehy, ED; Dwoskin, LP; Horton, DB; Nickell, JR; Siripurapu, KB; Vartak, A | 1 |
Chiang, YH; Harvey, BK; Pick, CG; Shen, H; Wang, Y | 1 |
Bubeníková-Valešová, V; Kačer, P; Kuzma, M; Najmanová, V; Rambousek, L; Slamberová, R; Syslová, K | 1 |
Goiny, M; Ichinose, F; Kehr, J; Nyberg, F; Sievertsson, T; Yoshitake, S; Yoshitake, T | 1 |
Good, RL; Liang, LP; Patel, M; Radcliffe, RA | 1 |
Chen, H; Fujita, Y; Hashimoto, K; Ishima, T; Iyo, M; Wu, J; Zhang, J | 1 |
Bourque, M; Di Paolo, T; Dluzen, DE | 1 |
Dluzen, DE; McDermott, JL; O'Connell, BP; Poth, LS | 1 |
Feiler, K; Groman, SM; James, AS; Jentsch, JD; Lee, B; London, ED; Mandelkern, MA; Seu, E | 1 |
Adair, JE; Barnes, C; Becker, KG; Brannock, C; Cadet, JL; Chiflikyan, M; Gold, MS; Goldberg, SR; Jayanthi, S; Justinova, Z; Kobeissy, FH; Krasnova, IN; Ladenheim, B; Lehrmann, E; McCoy, MT; Quintero, C | 1 |
Bardo, MT; Crooks, PA; Dwoskin, LP; Meyer, AC; Neugebauer, NM; Zheng, G | 1 |
Fleckenstein, AE; Hanson, GR; McFadden, LM; Vieira-Brock, PL | 1 |
Killinger, BA; Moszczynska, A | 1 |
Harvey, BK; Hinkle, JJ; Katz, JL; Kopajtic, T; Kuo, CC; Kyrkanides, S; Shen, H; Wang, Y; Yu, SJ | 1 |
Janphet, S; Nudmamud-Thanoi, S; Thanoi, S | 1 |
Dang, DK; Jang, CG; Jeong, JH; Kim, DJ; Kim, HC; Nabeshima, T; Nah, SY; Sato, H; Shin, EJ; Tran, HQ; Yoneda, Y | 1 |
Baumann, MH; Elmore, JS; Janowsky, A; Miner, NB; Phillips, TJ | 1 |
Doyle, KM; Kelly, JP; Moreira da Silva Santos, A | 1 |
Chen, J; Li, S; Wang, X; Wang, Y; Wang, Z; Zhai, H | 1 |
Burzynski, C; Cadet, JL; Gardner, EL; Jayanthi, S; Keck, TM; Ladenheim, B; Newman, AH; Schweppe, CA; van Praag, H; Xi, ZX | 1 |
Blough, BE; Gay, EA; Marusich, JA; Watson, SL | 1 |
Hassan, Z; Müller, CP; Murugaiyah, V; Yusoff, NHM | 1 |
Cadet, JL; Daiwile, AP; Goldstein, DS; Jayanthi, S; Sullivan, P | 1 |
181 other study(ies) available for methamphetamine and 3,4-dihydroxyphenylacetic acid
Article | Year |
---|---|
The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Haloperidol; Male; Methamphetamine; Motor Activity; Nomifensine; Rats; Rats, Sprague-Dawley; Synapses; Synaptic Transmission | 1992 |
Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Analysis of Variance; Animals; Aspartic Acid; Corpus Striatum; Designer Drugs; Dialysis; Dopamine; Glutamates; Kinetics; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; Rats; Rats, Wistar; Reference Values; Taurine; Time Factors | 1992 |
Subchronic methamphetamine treatment enhances ouabain-induced striatal dopamine efflux in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Autoradiography; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Kinetics; Male; Methamphetamine; Methyltyrosines; Ouabain; Perfusion; Rats; Rats, Inbred Strains; Reference Values; Reserpine; Sodium-Potassium-Exchanging ATPase; Tritium | 1992 |
MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Corpus Striatum; Dialysis; Dizocilpine Maleate; Dopamine; Male; Methamphetamine; Rats; Rats, Inbred Strains; Regression Analysis | 1992 |
Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Behavior, Animal; Benzamides; Benzazepines; Brain Chemistry; Corpus Striatum; Dialysis; Dopamine; Dopamine Antagonists; Homovanillic Acid; Male; Methamphetamine; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Synaptic Transmission | 1991 |
The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Motor Activity; Rats; Time Factors | 1990 |
Repeated injection of cocaine potentiates methamphetamine-induced toxicity to dopamine-containing neurons in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Cocaine; Corpus Striatum; Dopamine; Drug Synergism; Homovanillic Acid; Male; Methamphetamine; Neurons; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1991 |
Methamphetamine-induced dopamine release in the medial frontal cortex of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cerebral Cortex; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Frontal Lobe; Homovanillic Acid; Male; Methamphetamine; Rats; Rats, Inbred Strains | 1991 |
Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Male; Methamphetamine; Nervous System Diseases; Putamen; Rats; Rats, Inbred Strains | 1991 |
MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Dialysis; Dizocilpine Maleate; Dopamine; Drug Synergism; Male; Methamphetamine; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1991 |
Effect of intra-amygdala dopaminergic grafts on methamphetamine-induced locomotor activity, extracellular dopamine and dopamine metabolite overflow: a comparison with the effect of intra-accumbens grafts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Brain Tissue Transplantation; Dopamine; Electrophysiology; Homovanillic Acid; Hydroxydopamines; Male; Methamphetamine; Motor Activity; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains | 1991 |
MK-801 fails to modify the effect of methamphetamine on dopamine release in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Corpus Striatum; Dialysis; Dizocilpine Maleate; Dopamine; Male; Methamphetamine; Rats; Rats, Inbred Strains | 1991 |
Behavioral and biochemical effects of intra-accumbens dopaminergic grafts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Graft Survival; Hydroxydopamines; Male; Mesencephalon; Methamphetamine; Motor Activity; Neurotoxins; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Septal Nuclei | 1990 |
Catecholaminergic responses to rotational stress in rat brain stem: implications for amphetamine therapy of motion sickness.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Brain Stem; Disease Models, Animal; Homovanillic Acid; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Motion Sickness; Norepinephrine; Pica; Rats; Rats, Inbred Strains; Restraint, Physical; Rotation; Stress, Physiological | 1990 |
Neurochemical basis for cocaine and methamphetamine interactions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basal Ganglia; Cerebral Cortex; Cocaine; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1988 |
Lack of long-term monoamine depletions following repeated or continuous exposure to cocaine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Biogenic Monoamines; Brain; Brain Chemistry; Cocaine; Dopamine; Hydroxyindoleacetic Acid; Hypothalamus; Limbic System; Male; Methamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1988 |
Delta 9-tetrahydrocannabinol facilitates striatal dopaminergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Dronabinol; Female; Methamphetamine; Nomifensine; Rats; Rats, Inbred Strains | 1989 |
Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Tolerance; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Rats; Rats, Inbred Strains; Serotonin; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1985 |
Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; In Vitro Techniques; Male; Methamphetamine; Nalidixic Acid; Naphthyridines; Rats; Rats, Inbred Strains; Serotonin; Time Factors; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1985 |
Effect of dopamine receptor antagonist on in vivo dopamine release induced by intrastriatal perfusion with methamphetamine in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Kainic Acid; Male; Methamphetamine; Motor Activity; Perfusion; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1989 |
Methamphetamine: toxicity to dopaminergic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Dopamine; Guinea Pigs; Hydroxydopamines; Kinetics; Macaca mulatta; Methamphetamine; Mice; Nerve Endings; Neurons; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Rats; Receptors, Dopamine; Serotonin; Spiperone; Substance-Related Disorders | 1985 |
Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Drug Tolerance; Homovanillic Acid; Male; Methamphetamine; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1986 |
Regulation of dopamine release by the autoreceptor after repeated methamphetamine treatment in rats: an intracerebral dialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Male; Methamphetamine; Neural Pathways; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra | 1988 |
Haloperidol prevents the methamphetamine-induced apomorphine subsensitivity of dopamine metabolism in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Combinations; Haloperidol; Male; Methamphetamine; Rats; Rats, Inbred Strains | 1987 |
Atrophy of the striatum and motor disturbance induced by colchicine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Colchicine; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Methamphetamine; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1987 |
Reduced apomorphine sensitivity of dopamine metabolism in rat striatum after repeated administration of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Corpus Striatum; Dopamine; Injections, Intraperitoneal; Male; Methamphetamine; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Carrier Proteins; Cerebral Cortex; Citalopram; Clomipramine; Corpus Striatum; Dopamine; Male; Methamphetamine; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1985 |
Subchronic methamphetamine treatment selectively attenuates apomorphine-induced decrease in 3,4-dihydroxyphenylacetic acid level in mesolimbic dopaminergic regions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain Chemistry; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Frontal Lobe; Gyrus Cinguli; Male; Methamphetamine; Nucleus Accumbens; Olfactory Bulb; Phenylacetates; Rats; Receptors, Dopamine; Stereotyped Behavior | 1985 |
Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Limbic System; Male; Methamphetamine; Neurons; Rats; Rats, Inbred Strains; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase | 1983 |
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Male; Methamphetamine; Nerve Endings; Nucleus Accumbens; Rats; Rats, Inbred Strains; Substantia Nigra; Tegmentum Mesencephali; Tyrosine 3-Monooxygenase | 1982 |
Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Hydroxydopamines; Male; Methamphetamine; Nervous System Diseases; Oxidopamine; Rats; Rats, Inbred Strains | 1984 |
Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Hydrazines; Kinetics; Levodopa; Male; Methamphetamine; Putamen; Rats; Rats, Inbred Strains | 1983 |
Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Drug Synergism; Haloperidol; Homovanillic Acid; Limbic System; Male; Methamphetamine; Phenylacetates; Rats; Rats, Inbred Strains | 1981 |
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Combinations; Female; Humans; Levodopa; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Tyramine | 1982 |
Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Lamotrigine; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neostriatum; Neurons; Riluzole; Sodium Channels; Synaptic Transmission; Thiazoles; Triazines | 1995 |
Lack of mitigation of methamphetamine-induced neurotoxicity by ganglioside GM1 or vitamin E.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; G(M1) Ganglioside; Homovanillic Acid; Hydroxyindoleacetic Acid; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxins; Reactive Oxygen Species; Serotonin; Vitamin E | 1995 |
Low environmental temperatures or pharmacologic agents that produce hyperthermia decrease methamphetamine neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cold Temperature; Corpus Striatum; Dizocilpine Maleate; Dopamine; Haloperidol; Homovanillic Acid; Hypothermia; Hypothermia, Induced; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neuroprotective Agents; Neurotoxins; Pentobarbital; Phenobarbital | 1995 |
Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cerebral Cortex; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Humans; Hydroxyindoleacetic Acid; Methamphetamine; Mice; Mice, Transgenic; Neurotoxins; Serotonin; Superoxide Dismutase | 1994 |
Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Analysis of Variance; Animals; Biogenic Amines; Corpus Striatum; Dopamine; Glutamates; Glutamic Acid; Homovanillic Acid; Hydroxyindoleacetic Acid; Kinetics; Male; Methamphetamine; Microdialysis; Nucleus Accumbens; Rats; Rats, Wistar; Stereotaxic Techniques; Time Factors | 1994 |
Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Glutamic Acid; Humans; Hydroxyindoleacetic Acid; Methamphetamine; Mice; Mice, Transgenic; Neurotoxins; Nitric Oxide; Serotonin; Superoxide Dismutase; Superoxides | 1994 |
Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature Regulation; Chloride Channels; Cold Temperature; Corpus Striatum; Dizocilpine Maleate; Dopamine; Environmental Exposure; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Mice; Receptors, N-Methyl-D-Aspartate; Serotonin | 1994 |
Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Estrogens; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Mice; Orchiectomy; Ovariectomy; Sex Characteristics; Testosterone; Time Factors | 1994 |
Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Female; Frontal Lobe; Glutamates; Glutamic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methylaspartate; Phencyclidine; Pipecolic Acids; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley | 1993 |
Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Male; Methamphetamine; Oxidopamine; Pargyline; Pyrogallol; Rats; Rats, Sprague-Dawley; Reference Values; Time Factors | 1995 |
The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Chromatography, High Pressure Liquid; Dopamine; Dopamine Uptake Inhibitors; Immunohistochemistry; Male; Methamphetamine; Nalidixic Acid; Naphthyridines; Neostriatum; Nerve Degeneration; Nerve Endings; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 1994 |
Characterization of the in vivo action of (R)-salsolinol, an endogenous metabolite of alcohol, on serotonin and dopamine metabolism: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain Chemistry; Catecholamines; Chromatography, High Pressure Liquid; Dopamine; Ethanol; Isoquinolines; Male; Methamphetamine; Microdialysis; Neurons; Rats; Rats, Wistar; Serotonin | 1994 |
Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Caudate Nucleus; Chromatography, High Pressure Liquid; Cold Temperature; Dialysis; Dopamine; Female; Glutamates; Glutamic Acid; Hippocampus; Methamphetamine; Putamen; Rats; Rats, Sprague-Dawley; Serotonin; Taurine | 1993 |
Ontogeny of enhanced striatal dopamine release in rats with methamphetamine-induced behavioral sensitization.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Homovanillic Acid; Male; Methamphetamine; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley | 1994 |
The effect of repeated administration of methamphetamine on dopamine uptake sites in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding Sites; Corpus Striatum; Dopamine; Homovanillic Acid; Injections, Intraperitoneal; Mazindol; Methamphetamine; Osmolar Concentration; Rats; Rats, Wistar; Time Factors | 1994 |
MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Amino Acids, Cyclic; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Kynurenic Acid; Male; Methamphetamine; Mice; Mice, Inbred Strains; Receptors, Glycine; Strychnine; Substantia Nigra | 1993 |
Involvement of the fimbria fornix in the initiation but not in the expression of methamphetamine-induced sensitization.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Dopamine; Hippocampus; Homovanillic Acid; Male; Methamphetamine; Methyltyrosines; Motor Activity; Neural Pathways; Nucleus Accumbens; Rats; Rats, Wistar | 1993 |
Fluoro-gold and pentamidine inhibit the in vitro and in vivo release of dopamine in the striatum of rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Fluorescent Dyes; In Vitro Techniques; Male; Methamphetamine; Pentamidine; Potassium; Rats; Rats, Sprague-Dawley; Reserpine; Stilbamidines | 1993 |
Inhibitory effect of 4-phenyltetrahydroisoquinoline on locomotion and dopamine release induced by micro-injection of methamphetamine into the nucleus accumbens of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Cocaine; Dialysis; Dopamine; Homovanillic Acid; Isoquinolines; Male; Methamphetamine; Microinjections; Motor Activity; Nucleus Accumbens; Rats; Rats, Wistar; Tetrahydroisoquinolines | 1993 |
Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Cerebral Cortex; Chlormethiazole; Corpus Striatum; Dialysis; Dizocilpine Maleate; Dopamine; Hippocampus; Homovanillic Acid; Male; Methamphetamine; Potassium; Rats | 1993 |
Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Corpus Striatum; Dialysis; Dopamine; Dopamine D2 Receptor Antagonists; Male; Methamphetamine; Nerve Endings; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides | 1993 |
Characterization and transplantation of two neuronal cell lines with dopaminergic properties.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Bucladesine; Butyrates; Butyric Acid; Carrier Proteins; Cell Differentiation; Cell Line, Transformed; Cell Transplantation; Clone Cells; Cyclic AMP; Dopamine; Dopamine Plasma Membrane Transport Proteins; Intermediate Filament Proteins; Isoenzymes; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Mice; Nerve Tissue Proteins; Nestin; Neuroblastoma; Neurons; Oxidopamine; Phosphopyruvate Hydratase; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-delta; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 1996 |
Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Frontal Lobe; Homovanillic Acid; Male; Methamphetamine; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Serotonin; Sodium Chloride | 1996 |
The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Carrier Proteins; Cell Membrane; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Homovanillic Acid; Indazoles; Kinetics; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Nerve Tissue Proteins; Neurons; Neurotoxins; Nitric Oxide Synthase; Reference Values | 1996 |
Ontogeny of striatal dopamine release in rats after acute administration of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Female; Methamphetamine; Microdialysis; Pregnancy; Rats; Rats, Sprague-Dawley; Time Factors | 1996 |
Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Frontal Lobe; Male; Methamphetamine; Phencyclidine; Rats; Rats, Wistar; Time Factors | 1996 |
Modifications of the Brandel Superfusion 600 system and other revisions in superfusion technique improve the measurement of endogenous dopamine release in vitro.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; In Vitro Techniques; Male; Methamphetamine; Mice; Mice, Inbred Strains; Research Design | 1996 |
Methamphetamine-induced neurotoxicity is associated with increased striatal AP-1 DNA-binding activity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; DNA-Binding Proteins; Dopamine; Dose-Response Relationship, Drug; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neurotoxins; Transcription Factor AP-1 | 1996 |
Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Dopamine Agents; Enzyme Inhibitors; Homovanillic Acid; Indazoles; Male; Methamphetamine; Mice; Neostriatum; Neuroprotective Agents; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease, Secondary; Tyrosine 3-Monooxygenase | 1996 |
Methamphetamine-stimulated striatal dopamine release declines rapidly over time following microdialysis probe insertion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Artifacts; Corpus Striatum; Dopamine; Dopamine Agents; Infusions, Parenteral; Injections, Intraperitoneal; Male; Methamphetamine; Microdialysis; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Time Factors | 1996 |
Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Diazepam; Dizocilpine Maleate; Dopamine; Fever; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Phenobarbital; Rats; Serotonin; Temperature | 1996 |
The role of glutamate in the neurotoxic effects of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Glutamic Acid; Homovanillic Acid; Male; Methamphetamine; Microdialysis; Nucleus Accumbens; Rats; Rats, Wistar; Serotonin | 1996 |
Neurochemical analysis of the psychotoxicity of methamphetamine and cocaine by microdialysis in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Cognition Disorders; Corpus Striatum; Dopamine; Hydroxyindoleacetic Acid; Male; Methamphetamine; Microdialysis; Motor Activity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin | 1996 |
Alterations in electroencephalographic signals and monoamine concentrations in the rat brain following cocaine and methamphetamine treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cocaine; Dopamine; Electroencephalography; Homovanillic Acid; Methamphetamine; Rats; Rats, Sprague-Dawley; Serotonin | 1996 |
Dynamic regulation of striatal dopaminergic grafts during locomotor activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Transplantation; Corpus Striatum; Dopamine; Extracellular Space; Homovanillic Acid; Methamphetamine; Microdialysis; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Stereotyped Behavior; Substantia Nigra; Time Factors | 1996 |
Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Body Temperature; Brain; Catecholamines; Corpus Striatum; Dopamine; Frontal Lobe; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Isosorbide Dinitrate; Male; Methamphetamine; Mice; Mice, Inbred Strains; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Serotonin | 1997 |
Ginseng total saponin inhibits the dopaminergic depletions induced by methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Electrochemistry; Homovanillic Acid; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Panax; Plants, Medicinal; Saponins | 1997 |
[Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Glutamic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Microdialysis; Nitric Oxide; Nucleus Accumbens; Psychoses, Substance-Induced; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serotonin | 1997 |
Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Sequence; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Depressants; Clozapine; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Ethanol; Genotype; Humans; Levodopa; Locomotion; Maternal Behavior; Methamphetamine; Mice; Mice, Knockout; Molecular Sequence Data; Motor Activity; Mutagenesis, Site-Directed; Narcotics; Nucleus Accumbens; Receptors, Dopamine D2; Receptors, Dopamine D4; Sensitivity and Specificity; Substantia Nigra; Transcription, Genetic | 1997 |
N-methylation dissociates methamphetamine's neurotoxic and behavioral pharmacologic effects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Axons; Biomarkers; Biotransformation; Brain; Discrimination, Psychological; Dopamine; Dose-Response Relationship, Drug; Hydroxyindoleacetic Acid; Male; Methamphetamine; Methylation; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Reference Values; Serotonin | 1997 |
Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat-shock protein induction.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Body Temperature; Dopamine; Dopamine Uptake Inhibitors; Fever; Heat-Shock Proteins; Homovanillic Acid; Immunohistochemistry; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neostriatum; Neurotransmitter Agents | 1997 |
Increased expression of monoamine oxidase-B results in enhanced neurite degeneration in methamphetamine-treated PC12 cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Survival; Dopamine; Dopamine Agents; Hydrogen Peroxide; Lipid Peroxidation; Methamphetamine; Monoamine Oxidase; Nerve Degeneration; Neurites; PC12 Cells; Rats | 1997 |
Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Functional Laterality; Haloperidol; Homovanillic Acid; Kinetics; Levodopa; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Microdialysis; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Tritium; Tyrosine 3-Monooxygenase | 1998 |
Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Administration Schedule; Homovanillic Acid; Male; Methamphetamine; Microdialysis; Osmolar Concentration; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar | 1998 |
Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Indazoles; Male; Methamphetamine; Mice; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Temperature | 1998 |
Methamphetamine-induced modification of dopamine metabolism in cultured striatal astrocytes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Methamphetamine; Monoamine Oxidase Inhibitors; Oxidopamine; Rats; Rats, Sprague-Dawley | 1998 |
Methamphetamine-induced changes in activity and water intake during light and dark cycles in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Temperature; Brain; Circadian Rhythm; Corpus Striatum; Darkness; Dopamine; Dose-Response Relationship, Drug; Drinking Behavior; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus; Light; Male; Methamphetamine; Motor Activity; Rats; Rats, Wistar; Serotonin | 1998 |
Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzylamines; Biological Transport; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Kinetics; Locus Coeruleus; Male; Methamphetamine; Mice; Neurotransmitter Uptake Inhibitors; Norepinephrine; Sympathomimetics | 1999 |
Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Dopamine; Dopamine Uptake Inhibitors; Extracellular Space; Male; Methamphetamine; Microdialysis; Neostriatum; Nerve Tissue Proteins; Oxidation-Reduction; Quinones; Rats; Rats, Sprague-Dawley; Temperature | 1999 |
Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Dopamine; Dopamine Agents; Female; Homovanillic Acid; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Selenium | 1999 |
High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; Glutamic Acid; Immunohistochemistry; Male; Methamphetamine; Microscopy, Electron; Presynaptic Terminals; Rats; Rats, Sprague-Dawley | 1999 |
Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Glial Cell Line-Derived Neurotrophic Factor; Homovanillic Acid; Male; Methamphetamine; Microdialysis; Nerve Growth Factors; Nerve Tissue Proteins; Neuroprotective Agents; Rats; Rats, Inbred F344; Substantia Nigra | 1999 |
Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxins; Nitrates; Oxidants; Porphyrins; Reference Values; Tyrosine | 1999 |
Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Drug Administration Schedule; Electrochemistry; Homovanillic Acid; Injections, Subcutaneous; Male; Methamphetamine; Microdialysis; Neurotoxins; Nucleus Accumbens; Potassium; Presynaptic Terminals; Rats; Rats, Inbred F344; Time Factors; Wakefulness | 1999 |
Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Carrier Proteins; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fever; Gene Deletion; Homovanillic Acid; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neostriatum; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Time Factors | 1999 |
Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Caudate Nucleus; Dopamine; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurotoxins; Neurotrophin 3; Nitrates; Oxidants; PC12 Cells; Rats; Selenium; Sympathomimetics | 2000 |
Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Animals, Newborn; Brain; Caudate Nucleus; Disease Models, Animal; Dopamine; Dopamine Agonists; Entorhinal Cortex; Female; Homovanillic Acid; Methamphetamine; Microdialysis; Neurotoxins; Nucleus Accumbens; Prefrontal Cortex; Quinolinic Acid; Rats; Rats, Wistar; Schizophrenia; Temporal Lobe | 2000 |
Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Diet; Dopamine; Dopamine Agents; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Selenium; Substantia Nigra; Tyrosine 3-Monooxygenase | 2000 |
Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Behavior, Animal; Body Temperature; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Homovanillic Acid; Hydroxybenzoates; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Neurotoxicity Syndromes; Salicylic Acid; Self-Injurious Behavior; Species Specificity | 2000 |
Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Brain; Carrier Proteins; Cells, Cultured; Dopamine; Dopamine Plasma Membrane Transport Proteins; Intracellular Fluid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Mice; Nerve Tissue Proteins; Neuroblastoma; Neurons; Rats; Rats, Sprague-Dawley; Temperature | 2000 |
Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Drug Interactions; Functional Laterality; Homovanillic Acid; Male; Methamphetamine; Microdialysis; Neurotoxins; Potassium Chloride; Rats; Rats, Inbred F344; Time Factors | 2000 |
Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Cyclic N-Oxides; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Electrochemistry; Free Radical Scavengers; Homovanillic Acid; Imidazoles; Indazoles; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Models, Biological; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide; Peroxynitrous Acid; Tyrosine | 2000 |
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Area Under Curve; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Models, Biological; Neurotoxicity Syndromes; Sex Factors; Time Factors | 2000 |
Exposure of mice to tobacco smoke attenuates the toxic effect of methamphetamine on dopamine systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Dopamine Agents; Drug Interactions; Homovanillic Acid; Inhalation Exposure; Male; Methamphetamine; Mice; Mice, Inbred Strains; Nicotiana; Plants, Toxic; Serotonin; Smoke | 2000 |
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Analysis of Variance; Animals; Dopamine; Dopamine Agents; Drug Interactions; Electric Stimulation; Ganglionic Stimulants; In Vitro Techniques; Lobeline; Male; Methamphetamine; Motor Activity; Neurochemistry; Rats; Rats, Sprague-Dawley; Visual Cortex | 2001 |
Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Estradiol; Female; Homovanillic Acid; Methamphetamine; Microdialysis; Motor Activity; Ovariectomy; Rats; Rats, Sprague-Dawley; Reference Values; Time Factors | 2001 |
Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Body Temperature; Brain Chemistry; Cytoplasm; Dopamine; Dopamine Uptake Inhibitors; Male; Methamphetamine; Mice; Neurotoxicity Syndromes; Reserpine; Sympatholytics | 2001 |
Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Arousal; Dopamine; Female; Humans; Life Change Events; Methamphetamine; Norepinephrine; Prisoners; Psychoses, Substance-Induced; Recurrence; Risk Factors | 2001 |
Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain Chemistry; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Fever; Homovanillic Acid; Male; Methamphetamine; Nitrates; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tyrosine | 2001 |
A murine dopamine neuron-specific cDNA library and microarray: increased COX1 expression during methamphetamine neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; DNA, Complementary; Dopamine; Dopamine Uptake Inhibitors; Electron Transport Complex IV; Enzyme Induction; Female; Gene Expression Profiling; Gene Library; Genes, Synthetic; Lac Operon; Male; Mesencephalon; Methamphetamine; Mice; Mice, Transgenic; Molecular Sequence Data; Nerve Tissue Proteins; Neurons; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Rats; Transcription, Genetic; Tyrosine 3-Monooxygenase | 2001 |
Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Biomarkers; Brain; Cerebellum; Cerebral Cortex; Corpus Striatum; Dopamine; Hippocampus; Hydroxyindoleacetic Acid; Lipid Peroxidation; Male; Methamphetamine; Mice; Nerve Tissue Proteins; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Serotonin; Thiobarbituric Acid Reactive Substances | 2001 |
Methamphetamine produces subsequent reductions in running time to exhaustion in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Cardiovascular Physiological Phenomena; Dopamine; Dopamine Uptake Inhibitors; Fatigue; Hypothalamus; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Myocardium; Neostriatum; Neural Pathways; Norepinephrine; Physical Conditioning, Animal; Substantia Nigra | 2001 |
Fetal exposure to methamphetamine in utero stimulates development of serotonergic neurons in three-dimensional reaggregate tissue culture.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Brain; Cell Aggregation; Cells, Cultured; Dopamine; Female; Fetus; Homovanillic Acid; Hydroxyindoleacetic Acid; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Serotonin; Up-Regulation | 2002 |
Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Northern; Brain; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Electron Transport Complex IV; Gene Expression Regulation; Hypothermia, Induced; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Methamphetamine; Mice; Nerve Tissue Proteins; Neurons; Nucleic Acid Synthesis Inhibitors; Oligonucleotide Array Sequence Analysis; Protein Subunits; Protein Synthesis Inhibitors; RNA, Messenger; Synaptosomes; Tissue Distribution | 2002 |
Effect of low doses of L-NAME on methamphetamine-induced dopaminergic depletion in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Fever; Injections, Subcutaneous; Male; Methamphetamine; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Serotonin | 2001 |
Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Excitatory Amino Acid Antagonists; Fever; Glial Fibrillary Acidic Protein; Homovanillic Acid; Hydroxybenzoates; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Inbred C57BL; Microdialysis; Nerve Tissue Proteins; Pyridines; Reactive Oxygen Species; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Tyrosine 3-Monooxygenase | 2002 |
Short toxic methamphetamine schedule impairs object recognition task in male rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Drug Administration Schedule; Exploratory Behavior; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Serotonin; Spatial Behavior | 2002 |
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caspase 3; Caspases; Catecholamines; Cell Survival; Cells, Cultured; Cysteine; Cysteinyldopa; DNA; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Intracellular Fluid; Levodopa; Methamphetamine; Neurons; Purines; Pyrimidines; Rats; Reactive Oxygen Species | 2002 |
Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Behavior, Animal; Binding Sites; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Homovanillic Acid; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Motor Activity; Nerve Tissue Proteins; Neurotoxins | 2002 |
Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Amphetamines; Animals; Caudate Nucleus; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin | 2002 |
Acute changes in dopamine release and turnover in rat caudate nucleus following a single dose of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Amphetamine-Related Disorders; Animals; Caudate Nucleus; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Homovanillic Acid; Male; Methamphetamine; Presynaptic Terminals; Rats; Rats, Sprague-Dawley | 2002 |
Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Behavior, Animal; Brain; Brain Chemistry; Dopamine; gamma-Aminobutyric Acid; Histamine; Histidine Decarboxylase; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Mice; Mice, Inbred Strains; Mice, Knockout; Motor Activity; Norepinephrine; Phosphoserine; Photoperiod; Serotonin | 2002 |
Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Binding, Competitive; Body Temperature; Cell Death; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Synergism; Gene Products, tat; HIV-1; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Intracellular Membranes; Male; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Methamphetamine; Mitochondria; Nerve Tissue Proteins; Neurons; Rats; Rats, Sprague-Dawley; Serotonin; tat Gene Products, Human Immunodeficiency Virus | 2002 |
Lobeline does not serve as a reinforcer in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Conditioning, Operant; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Infusions, Intravenous; Lobeline; Male; Methamphetamine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration | 2003 |
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Homovanillic Acid; Methamphetamine; Microdialysis; Motor Activity; Nucleus Accumbens; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Time Factors; Valine | 2003 |
The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Body Weight; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Operant; Dopamine; Female; Hydroxyindoleacetic Acid; Male; Methamphetamine; Neostriatum; Neurotoxicity Syndromes; Nucleus Accumbens; Prefrontal Cortex; Rats; Reward; Serotonin; Sex Characteristics | 2003 |
Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Binding Sites; Binding, Competitive; Body Weight; Central Nervous System Stimulants; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Dopamine; Female; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Sex Characteristics; Time Factors | 2003 |
Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; alpha-Synuclein; Animals; Antibodies; Blastomeres; Blotting, Southern; Corpus Striatum; Disease Models, Animal; DNA Primers; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hippocampus; Homovanillic Acid; Humans; Immunoblotting; Immunohistochemistry; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; MPTP Poisoning; Nerve Tissue Proteins; Neurons; Parkinsonian Disorders; Piperazines; Rats; Reserpine; Serotonin; Stem Cells; Subcellular Fractions; Substantia Nigra; Synucleins; Tyrosine 3-Monooxygenase | 2003 |
Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Binding Sites; Body Temperature; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Homovanillic Acid; Male; Methamphetamine; Motor Activity; Neostriatum; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Tetrabenazine; Time Factors; Tritium | 2003 |
Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amides; Animals; Behavior, Animal; Central Nervous System Stimulants; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Routes; Enzyme Inhibitors; Extracellular Space; Homovanillic Acid; Intracellular Signaling Peptides and Proteins; Male; Methamphetamine; Microdialysis; Morphine; Narcotics; Nucleus Accumbens; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Tetrodotoxin | 2003 |
Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; Cytoprotection; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gliosis; Homovanillic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Knockout; Microdialysis; Motor Activity; MPTP Poisoning; Nerve Tissue Proteins; Prazosin; Receptors, Adrenergic, alpha-1; Tyrosine 3-Monooxygenase | 2003 |
Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Interactions; Estrogens; Female; Methamphetamine; Mice; Neostriatum; Neural Pathways; Neuroprotective Agents; Neurotoxins; Ovariectomy; Parkinson Disease; Presynaptic Terminals; Reaction Time; Sex Factors; Substantia Nigra | 2003 |
4-Hydroxytamoxifen attenuates methamphetamine-induced nigrostriatal dopaminergic toxicity in intact and gonadetomized mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Body Temperature; Castration; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Estrogen Antagonists; Female; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neostriatum; Neurotoxins; Sex Factors; Superoxide Dismutase; Tamoxifen; Time Factors; Xanthine Oxidase | 2003 |
Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport Proteins; Heterozygote; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Neostriatum; Nerve Tissue Proteins; Receptors, Dopamine D2; Receptors, Dopamine D3; Tyrosine 3-Monooxygenase | 2004 |
Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Chromatography, High Pressure Liquid; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Interactions; Estradiol; Female; In Situ Hybridization; Iodine Isotopes; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Neostriatum; Nerve Tissue Proteins; Nervous System Diseases; Neuroprotective Agents; Ovariectomy; Protein Binding; RNA, Messenger; Substantia Nigra; Time Factors | 2004 |
Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Estrogen Antagonists; Estrogens; Female; Methamphetamine; Mice; Movement; Neostriatum; Neurotoxins; Organ Size; Ovariectomy; Stereotyped Behavior; Substantia Nigra; Tamoxifen; Uterus | 2004 |
Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Central Nervous System Stimulants; Dopamine; Homovanillic Acid; Injections, Intravenous; Male; Methamphetamine; Motor Activity; Nerve Endings; Putamen; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Time Factors | 2005 |
Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Animals; Anisomycin; Blotting, Western; Corpus Striatum; Dopamine; Electrophoresis, Gel, Two-Dimensional; Fever; Male; Mass Spectrometry; Methamphetamine; Mice; Mice, Inbred Strains; Nerve Tissue Proteins; Neurotoxins; Protein Synthesis Inhibitors; Substantia Nigra; Synucleins; Ubiquitin; Ubiquitin Thiolesterase | 2005 |
Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Blotting, Western; Central Nervous System Stimulants; Dopamine; Drug Synergism; Gene Products, tat; Male; Methamphetamine; Neostriatum; Nerve Degeneration; Nerve Endings; Nerve Fibers; Oxidative Stress; Rats; Rats, Sprague-Dawley; Silver Staining; Substantia Nigra; Tyrosine 3-Monooxygenase | 2006 |
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Cell Count; Chemokine CCL2; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Homovanillic Acid; Interleukin-6; Male; Methamphetamine; Mice; Mice, Mutant Strains; Microglia; Minocycline; Neurons; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tyrosine 3-Monooxygenase | 2006 |
Rotenone produces opposite effects upon mouse striatal dopamine function as a result of environmental temperature.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Insecticides; Methamphetamine; Mice; Rotenone; Temperature | 2006 |
Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Caspase 3; Caspases; Caudate Nucleus; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dopamine; Dopamine Uptake Inhibitors; Electrochemistry; Homovanillic Acid; Male; Methamphetamine; Microdialysis; Putamen; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2006 |
Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Estrogens; Female; Male; Methamphetamine; Mice; Nerve Degeneration; Neural Pathways; Neuroprotective Agents; Neurotoxins; Orchiectomy; Ovariectomy; Parkinsonian Disorders; Substantia Nigra | 2006 |
Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Amphetamine-Related Disorders; Animals; Body Temperature; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cocaine; Dopamine Uptake Inhibitors; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Male; Methamphetamine; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley | 2006 |
Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Androgens; Animals; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Estrogen Antagonists; Female; Methamphetamine; Mice; Neostriatum; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Ovariectomy; Parkinson Disease; Substantia Nigra; Tamoxifen | 2006 |
Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Blotting, Southern; Central Nervous System Stimulants; Dopa Decarboxylase; Dopamine; Dopamine Antagonists; Exons; Methamphetamine; Mice; Mice, Knockout; Neostriatum; Positron-Emission Tomography; Postural Balance; Raclopride; Radiopharmaceuticals; Receptors, Dopamine; Sensory Receptor Cells; Ubiquitin-Protein Ligases | 2006 |
Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Drug Combinations; Drug Synergism; Extracellular Matrix; Methamphetamine; Microdialysis; Models, Biological; Morphine; Rats; Rats, Sprague-Dawley; Time Factors | 2006 |
Effects of postnatal exposure to methamphetamine on the development of the rat retina.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Size; Disease Models, Animal; Dopamine; Female; Male; Methamphetamine; Postnatal Care; Rats; Rats, Inbred BB; Retina; Tyrosine 3-Monooxygenase | 2006 |
Attenuation of methamphetamine-induced nigrostriatal dopaminergic neurotoxicity in mice by lipopolysaccharide pretreatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basal Ganglia; Body Temperature; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Synergism; Fever; Lipopolysaccharides; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Receptors, Dopamine | 2007 |
Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Blotting, Western; Body Weight; Caudate Nucleus; Chromatography, High Pressure Liquid; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Immunochemistry; Infusion Pumps, Implantable; Injections, Subcutaneous; Male; Mesencephalon; Methamphetamine; Phosphorylation; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Selegiline; Substantia Nigra; Synapses; Time Factors; Tyrosine 3-Monooxygenase | 2007 |
Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Methamphetamine; Mice; Mice, Knockout; Microdialysis; Receptors, Opioid, mu; Serotonin | 2008 |
Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Cerebrum; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Male; Methamphetamine; Mice; Motor Activity; Nucleus Accumbens; Oxytocin; Prefrontal Cortex; Receptors, Oxytocin; Serotonin; Vasotocin | 2008 |
Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Down-Regulation; Female; Gene Expression Regulation; Heterozygote; Male; Methamphetamine; Mice; Mice, Knockout; Mutation; Neural Pathways; Potassium Chloride; Sex Characteristics; Substantia Nigra; Synaptic Transmission; Up-Regulation | 2008 |
Differential regional effects of methamphetamine on dopamine transport.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biological Transport; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Hypothalamus; Male; Methamphetamine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Vesicular Monoamine Transport Proteins | 2008 |
Sex differences in dopamine- and vesicular monoamine-transporter functions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Behavior; Behavior, Animal; Corpus Striatum; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Methamphetamine; Mice; Nomifensine; Reserpine; Sex Factors; Vesicular Monoamine Transport Proteins | 2008 |
A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Space; Fever; Male; Methamphetamine; Motor Activity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration | 2009 |
Acrylamide decreased dopamine levels and increased 3-nitrotyrosine (3-NT) levels in PC 12 cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acrylamide; Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemical Techniques; Homovanillic Acid; Methamphetamine; Neurons; PC12 Cells; Rats; Time Factors; Tyrosine | 2009 |
Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Homovanillic Acid; Male; Methamphetamine; Motor Activity; Neural Pathways; Nucleus Accumbens; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Time; Ventral Tegmental Area | 2009 |
Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Biogenic Monoamines; Brain Chemistry; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cues; Dopamine; Dopamine Plasma Membrane Transport Proteins; Extinction, Psychological; Male; Methamphetamine; Neostriatum; Prefrontal Cortex; Rats; Rats, Long-Evans; Recurrence; Self Administration; Serotonin Plasma Membrane Transport Proteins | 2009 |
Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Fever; Hyperkinesis; Immunohistochemistry; Male; Methamphetamine; Mice; Motor Activity; Neuroprotective Agents; Plicamycin; Protein Synthesis Inhibitors | 2009 |
Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Evaluation, Preclinical; Lobeline; Male; Methamphetamine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Synaptic Vesicles; Synaptosomes; Vesicular Monoamine Transport Proteins | 2010 |
Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basal Ganglia; Central Nervous System Stimulants; Cerebral Cortex; Clorgyline; Conditioning, Classical; Corpus Striatum; Dose-Response Relationship, Drug; Locomotion; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Norepinephrine; Nucleus Accumbens; Rats; Rats, Inbred F344; Serotonin; Space Perception; Time Factors | 2010 |
Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Female; In Vitro Techniques; Male; Methamphetamine; Mice; Neurotoxicity Syndromes; Sex Factors; Time Factors | 2010 |
Red wine but not ethanol at low doses can protect against the toxicity of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Central Nervous System Depressants; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dopamine; Ethanol; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxicity Syndromes; Wine | 2010 |
The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aconitine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Cell Membrane; Conditioning, Operant; Corpus Striatum; Dopamine; Drug Tolerance; Lobeline; Male; Methamphetamine; Nicotine; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2010 |
Methamphetamine potentiates behavioral and electrochemical responses after mild traumatic brain injury in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Injuries; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Methamphetamine; Mice; Motor Activity; Severity of Illness Index | 2011 |
Monitoring of dopamine and its metabolites in brain microdialysates: method combining freeze-drying with liquid chromatography-tandem mass spectrometry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, Liquid; Dopamine; Drug Stability; Female; Freeze Drying; Homovanillic Acid; Linear Models; Methamphetamine; Microdialysis; Nucleus Accumbens; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2011 |
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Chromatography, High Pressure Liquid; Dopamine; Hydroxyindoleacetic Acid; Locomotion; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin | 2011 |
Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Amphetamine-Related Disorders; Animals; Basal Ganglia; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Dopamine Agents; Down-Regulation; Genotype; Male; Methamphetamine; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Inbred DBA; Phenotype; Prefrontal Cortex; Signal Transduction; Species Specificity; Time Factors; Tyrosine 3-Monooxygenase | 2011 |
Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Basal Ganglia; Behavior, Animal; Dopamine; Dose-Response Relationship, Drug; Isothiocyanates; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Microglia; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Sulfoxides; Thiocyanates | 2012 |
Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Male; MAP Kinase Signaling System; Methamphetamine; Mice; Proto-Oncogene Proteins c-akt; Sex Characteristics; Signal Transduction; Time Factors | 2012 |
Nomifensine alters sex differences in striatal dopaminergic function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neostriatum; Nomifensine; Sex Characteristics | 2012 |
Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Chlorocebus aethiops; Choice Behavior; Discrimination Learning; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Feedback, Sensory; Homovanillic Acid; Magnetic Resonance Imaging; Male; Methamphetamine; Positron-Emission Tomography; Receptors, Dopamine D2; Retention, Psychology; Reversal Learning; Synaptic Transmission; Time Factors | 2012 |
CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Stimulants; Conditioning, Operant; Corpus Striatum; CREB-Binding Protein; Disease Models, Animal; Dopamine; Gene Expression Profiling; Gene Expression Regulation; Hydroxyindoleacetic Acid; Male; Methamphetamine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Self Administration; Serotonin; Substance-Related Disorders; Time Factors | 2013 |
Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain Chemistry; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Uptake Inhibitors; Electrochemistry; Extracellular Space; Lobeline; Male; Methamphetamine; Microdialysis; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2013 |
Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Conditioning, Operant; Dopamine; Dopamine Agents; Drug Administration Schedule; Glial Fibrillary Acidic Protein; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Self Administration; Time Factors; Tritium; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2015 |
Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Epothilones; Exploratory Behavior; Glial Fibrillary Acidic Protein; Homovanillic Acid; Male; Methamphetamine; Microtubules; Motor Activity; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tubulin; Tyrosine 3-Monooxygenase | 2016 |
Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of Mu opioid receptors in nucleus accumbens and ventral tegmental area.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Gene Expression Regulation; Humans; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microinjections; Motor Activity; Nucleus Accumbens; Receptors, Opioid, mu; Ventral Tegmental Area | 2016 |
Alteration of catecholamine concentrations in rat testis after methamphetamine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Illicit Drugs; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Reproduction; Testis | 2017 |
The role of system Xc
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Transport System y+; Animals; Corpus Striatum; Dopamine; Glutamic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Oxidative Stress; Reactive Oxygen Species | 2017 |
Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Temperature Regulation; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotoxicity Syndromes; Receptors, G-Protein-Coupled; Time Factors; Tyrosine 3-Monooxygenase | 2017 |
Dose-Dependent Effects of Binge-Like Methamphetamine Dosing on Dopamine and Neurotrophin Levels in Rat Brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Central Nervous System Stimulants; Dopamine; Dose-Response Relationship, Drug; Gene Expression Regulation; Homovanillic Acid; Levodopa; Locomotion; Male; Methamphetamine; Nerve Growth Factors; Rats; Rats, Sprague-Dawley; Time Factors | 2017 |
Melatonin pretreatment attenuates acute methamphetamine-induced aggression in male ICR mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aggression; Animals; Brain; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Melatonin; Methamphetamine; Mice; Mice, Inbred ICR; Serotonin | 2019 |
Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Stimulants; Cognition; Dopamine; Dopamine Plasma Membrane Transport Proteins; Hippocampus; Hydroxyindoleacetic Acid; Male; Maze Learning; Memory Disorders; Methamphetamine; Rats; Rats, Wistar; Self Administration | 2020 |
Alpha-pyrrolidinopentiophenone and mephedrone self-administration produce differential neurochemical changes following short- or long-access conditions in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Female; Hydroxyindoleacetic Acid; Male; Methamphetamine; Neurotransmitter Agents; Norepinephrine; Pentanones; Pyrrolidines; Rats, Sprague-Dawley; Self Administration; Serotonin; Sex Factors; Time Factors | 2021 |
The effect of mitragynine on extracellular activity of brain dopamine and its metabolites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Methamphetamine; Mitragyna; Morphine; Narcotics; Prefrontal Cortex; Rats; Secologanin Tryptamine Alkaloids | 2022 |
Sex-Specific Alterations in Dopamine Metabolism in the Brain after Methamphetamine Self-Administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Female; Male; Methamphetamine; Nucleus Accumbens; Rats; Self Administration | 2022 |